Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

23

Revenue 2017

Teva

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.

Teva

Havas Lynx Group and VCCP Health win big at PM Society Awards

Havas Lynx Group and VCCP Health win big at PM Society Awards

Craft Award for Film &Animation (Patients): VCCP Health for Teva. Craft Award for Interactive Communications: Havas Lynx Group for Teva. ... Best Use of Insight: Havas Lynx Group for Roche. Best of Show: VCCP Health for Teva.

Blood will out

Blood will out For every spectacular success, such as Gilead’s Pharmasset deal, there were several embarrassing flops, like Teva’s purchase of Allergan’s generic assets.

The year in review

The year in review In 2019, we saw an avalanche of legal manoeuvrings and proposed settlements with companies like Purdue, Johnson and Johnson, McKesson, AmeriSource Bergen, Cardinal Health and Teva now offering to pay jurisdictions

Allergan gets FDA nod for first oral CGRP drug for migraine

Allergan gets FDA nod for first oral CGRP drug for migraine First to market among these the injectables was Amgen/Novartis’ Aimovig (erenumab), and it has since been joined by Eli Lilly’s Emgality (galcanezumab) and Teva’s Ajovy (fremanezumab), with intravenous

J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial

J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial Oklahoma also sued Teva Pharmaceuticals and Purdue Pharma, with both of these companies ultimately deciding to settle out of court (for $85m and $270m respectively).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics